在世界抗生(sheng)(sheng)(sheng)(sheng)(sheng)素(su)(su)意識周(11月18-24日)期間發起(qi)的(de)(de)(de)一項新(xin)的(de)(de)(de)全(quan)球(qiu)(qiu)研(yan)究顯(xian)示，治療喉嚨痛(tong)(tong)等呼吸系統(tong)疾(ji)病(bing)(bing)對(dui)抗生(sheng)(sheng)(sheng)(sheng)(sheng)素(su)(su)的(de)(de)(de)依(yi)賴程度很高(gao)，抗生(sheng)(sheng)(sheng)(sheng)(sheng)素(su)(su)耐藥性(xing)(xing)是全(quan)球(qiu)(qiu)第(di)三大死亡原因，每(mei)年(nian)導致495萬(wan)人死亡。由全(quan)球(qiu)(qiu)呼吸道(dao)感染伙伴關系(GRIP)和Strepsils制(zhi)造商利潔時委托進行的(de)(de)(de)咽痛(tong)(tong)與抗生(sheng)(sheng)(sheng)(sheng)(sheng)素(su)(su)耐藥性(xing)(xing)(STAR)研(yan)究發現，在過(guo)去6個月里，超過(guo)一半的(de)(de)(de)受訪成年(nian)人服用過(guo)抗生(sheng)(sheng)(sheng)(sheng)(sheng)素(su)(su)來(lai)治療喉嚨痛(tong)(tong)等呼吸道(dao)疾(ji)病(bing)(bing)，盡管抗生(sheng)(sheng)(sheng)(sheng)(sheng)素(su)(su)對(dui)十分之九的(de)(de)(de)咽痛(tong)(tong)無效(xiao)。(美通社頭條(tiao))